Subsequent studies have shown that targeting glycolysis through inhibition of the lactate transporter, monocarboxylate transporter 1 (MCT1), is effective in preclinical models of SCLC and shows synergy with radiotherapy (Table 2) [124,209]. The gene discussed is SLC16A1; the disease is small cell lung carcinoma.